Neuroendocrine Tumors of Non-Pancreatic Origin
1 clinical trials · Condition
◉ Watch Neuroendocrine Tumors of Non-Pancreatic Origin
| Record | Firm | Date |
|---|---|---|
| Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma (NCT01177397) | Celgene | 2010-07-20 |
Track Neuroendocrine Tumors of Non-Pancreatic Origin automatically
Every clearance here is in the API, with alerts when new ones post.